COMPARISON OF VASCULAR EFFECTS OF ROPIVACAINE AND LIDOCAINE ON ISOLATED RINGS OF HUMAN ARTERIES

Citation
G. Gherardini et al., COMPARISON OF VASCULAR EFFECTS OF ROPIVACAINE AND LIDOCAINE ON ISOLATED RINGS OF HUMAN ARTERIES, Acta anaesthesiologica Scandinavica, 39(6), 1995, pp. 765-768
Citations number
14
Categorie Soggetti
Anesthesiology
ISSN journal
00015172
Volume
39
Issue
6
Year of publication
1995
Pages
765 - 768
Database
ISI
SICI code
0001-5172(1995)39:6<765:COVEOR>2.0.ZU;2-P
Abstract
Ropivacaine is a new local anaesthetic agent. Previous animal studies have indicated that vasoconstrictor effects are elicited by ropivacain e in vitro and subcutaneously and that it produces blanching of the sk in if injected subcutaneously in humans. Lidocaine is a widely used lo cal anaesthetic reported to exert a biphasic effect on the microvascul ature with contraction at low concentrations and relaxation at high co ncentrations. There is a need for pharmacologic tools able to countera ct local arterial vasoconstriction. In this study, the contractile eff ect of ropir;acaine and lidocaine were investigated in vitro on isolat ed human arteries. Experiments were performed on 43 internal mammary a rtery (IMA) rings obtained from 22 patients and on 14 radial artery (R A) rings from 7 patients. The rings were mounted in organ baths and is ometric contractile activity was measured. Experiments were conducted by cumulative adding ropivacaine or lidocaine (1.5x10(-5) M; 4.5x10(-5 ) M; 1.5x10(-4) M; 4.5x10(-4) M; 1.5x10(-3) M; 4.5x10(-3) M; 1.5x10(-2 ) M) to the organ baths. The endothelium was mechanically removed in 1 9 IMA rings and in 9 RA rings. Ropivacaine and lidocaine produced a bi phasic response with contraction at low concentrations (1.5x10(-5)-1.5 x10(-3) M) and release of the maximal contraction at higher concentrat ions. No statistically significant differences in contractile or relax ing effects were seen between the two drugs. Removal of the endotheliu m did not significantly affect contractile activity. In this study of human mammary artery preparations, ropivacaine is not a stronger vasoc onstrictor than lidocaine.